Spectrum Pharmaceuticals, Inc. (SPPI) stock is lower by 11.84% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With SPPI Stock Today?
Spectrum Pharmaceuticals, Inc. (SPPI) stock is trading at $4.32 as of 3:26 PM on Friday, Sep 25, an increase of $0.09, or 2.01% from the previous closing price of $4.23. The stock has traded between $4.20 and $4.42 so far today. Volume today is 2,578,374 compared to average volume of 2,668,305.
To see InvestorsObserver's Sentiment Score for Spectrum Pharmaceuticals, Inc. click here.
More About Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.
Click Here to get the full Stock Score Report on Spectrum Pharmaceuticals, Inc. (SPPI) Stock.